Board Meeting Announcement for Gennex Laboratories Ltd - May 30, 2025

Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve 1. Consider and adopt the Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended March 31 2025; 2. Consider the Independent Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the quarter and year ended March 31 2025; 3. Other Business items. Further in continuation to earlier disclosure dated March 26 2025 regarding the closure of trading window w.e.f. April 01 2025 in pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended Trading Window for dealing in the securities of the Company shall open after 48 hours of declaration of Audited Financial Results for the quarter and year ended March 31 2025 for all designated persons their immediate relatives and all connected persons covered under the aforesaid code. This intimation is also being uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same.